Loading quotes...

Forecast

The analysts' average price target is €16.31 (-25.49%). The median is €16.02 (-26.82%).

Buy	2
Hold	7
Sell	2

News Go to news feed

ProAssurance reaches 52-week high and makes progress on acquisition by The Doctors Company

Shares of ProAssurance Corp. hit a new 52-week high at $23.96, marking an increase of over 100% in the past year. The planned acquisition by The Doctors Company is moving forward after the US antitrust authority ended the waiting period early and shareholders approved the transaction by a large majority. The acquisition is expected to close in the first half of 2026, pending further regulatory approvals. » More on de.investing.com
ProAssurance reaches 52-week high as shareholders approve acquisition by The Doctors Company

ProAssurance shares hit a new 52-week high at $23.95, showing strong performance over the past year. Shareholders overwhelmingly approved the planned acquisition by The Doctors Company, with over 99% voting in favor. The deal is expected to close in the first half of 2026, pending regulatory approvals. After the acquisition, ProAssurance will become a wholly owned subsidiary of The Doctors Company and will be delisted from the New York Stock Exchange. » More on de.investing.com
ProAssurance hits 52-week high ahead of acquisition by The Doctors Company

Shares of ProAssurance reached a new 52-week high after shareholders overwhelmingly approved the planned acquisition by The Doctors Company. The deal is expected to close in the first half of 2026, pending further regulatory approvals, after which ProAssurance will be delisted. However, analysts have raised concerns about the valuation and the company's future earnings potential. » More on de.investing.com

Historical dividends Dividends

All dividend metrics All metrics

In 2023, Proassurance Co. has already paid €0.0918 in dividends. The last payout was in April 2023.

Financials

In the last quarter, Proassurance Co. had revenue of €226.89m and net profit of €7.31m

(EUR)	March 2026	YoY
Revenue	226.89m	-
Gross profit	76.4m	-
Net profit	7.31m	-
EBITDA	14.85m	-

Fundamentals

Metric	Value
Market capitalization	€1.15bn
Number of shares	51.61m
52-week high/low	€22.27 - €20.29
Dividends	No
Beta	0.04
P/E ratio	19.71
PEG ratio	0.37
P/B ratio	0.96
P/S ratio	1.20

Company profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers' Compensation Insurance, Segregated Portfolio Cell Reinsurance, and Lloyd's Syndicate segments. It offers professional liability insurance for healthcare providers and institutions, and attorneys; liability insurance for medical technology and life sciences risks; and workers' compensation insurance, such as guaranteed cost policies, policyholder dividend policies, retrospectively rated policies, and deductible policies, as well as alternative market solutions that include program design, fronting, claims administration, risk management, SPC rental, asset management, and SPC management services for individual companies, agencies, groups, and associations. The company also participates in Lloyd's of London Syndicate 1729, which underwrites property and casualty insurance, and reinsurance. It markets its products through independent agencies and brokers, as well as an internal sales force. The company was founded in 1976 and is headquartered in Birmingham, Alabama.

Name	Proassurance Co.
CEO	Edward Lewis Rand Jr.
Headquarters	Birmingham, al USA
Website	proassurance.com
Sector	Financials
Industry	Insurance
IPO	04/09/1991
Employees	972